Global or Regional Licensing Partnership
NOBO Medicine is actively seeking partners to collaborate on the development of Poseltinib for hematologic cancers and Emricasan for inflammatory diseases.
NOBO Medicine is actively seeking partners to collaborate on the development of Poseltinib for hematologic cancers and Emricasan for inflammatory diseases.
NOBO Medicine is recruiting talented individuals to join us in realizing our vision.
NOBO Medicine, Inc.
#1-721, Sungsu SKV1 center, 48 Achasan-ro 17-gil, Seongdong-gu, Seoul, Republic of Korea (04799)
